BLACKSHEARJL, NAPLERJS, DAVIDMANM, STILLMANMT. Renal complications of nonsteroidal antiinflammatory drugs: identification and monitoring of those at risk. Semin Arthritis Rheum1985; 14: 163-75.
2.
ZIPSERRD, HENRICHWL. Implications of nonsteroidal anti-inflammatory drug therapy. Am J Med1986; 80: 78-84.
3.
HARTD, WARDM, LIFSHITZMD. Suprofen-related nephrotoxicity. Ann Intern Med1987; 106: 235-8.
4.
BRATERDC. Clinical aspects of renal prostaglandins and NSAID therapy. Semin Arthritis Rheum1988; 17(suppl 2): 16-22.
5.
PATRONOC, DUNNMJ. The clinical significance of inhibition of renal prostaglandin synthesis. Kidney Int1987; 32: 1-12.
6.
CLIVEDM, STOFFJS. Renal syndromes associated with nonsteroidal anti-inflammatory drugs. N Engl J Med1984; 310: 563-72.
7.
WILLIAMSRL, FURSTDE, MANDELHG, NICOLLD, KONIKOFFJJ, BENETLZ. Effects of indomethacin and carprofen on renal homeostasis in rheumatoid arthritis patients and in healthy individuals. J Clin Phamacol1981; 21: 493-500.
8.
CUMMINGSDM, AMADIOP, NETTLERS, FRIEDMANM. Evaluation of renal function in elderly patients receiving NSAID's (abstract). Clin Pharmacol Ther1988; 43: 179.
9.
TURNERR. Hepatic and renal tolerability of long-term naproxen treatment in patients with rheumatoid arthritis. Semin Arthritis Rheum1988; 17(suppl 2): 29-35.
10.
LINDERMANRD, TOBINJ, SHOCKNW. Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc1985; 33: 278-85.
11.
BLACKSHEARJL, DAVIDMANM, STILLMANMT. Identification of risk for renal insufficiency from nonsteroidal anti-inflammatory drugs. Arch Intern Med1983; 143: 1130-4.
12.
BRATERDC. Drug-drug and drug-disease interactions with non-steroidal anti-inflammatory drugs. Am J Med1986; 80: 62-77.
13.
UPTONRA, WILLIAMSRL, KELLYJ, JONESRM. Naproxen pharmacokinetics in the elderly. Br J Clin Pharmacol1984; 18: 207-14.
14.
BRATERDC, ANDERSONSA, BROWN-CARTWRIGHTDB, TOTORD, CHENA, JACOBGB,. Effect of etodolac in patients with moderate renal impairment compared with normal subjects. Clin Pharmacol Ther1985; 38: 674-9.
15.
BRATERDC, BROWN-CARTWRIGHTD, ANDERSONSA, UAAMNUICHAIM. Effect of high-dose etodolac on renal function. Clin Pharmacol Ther1987; 42: 283-9.
16.
WATSONWA, FREERJP, KATZRS, BASCHC. Kidney function during naproxen therapy in patients at risk for renal insufficiency. Semin Arthritis Rheum1988; 17(suppl 2): 12-6.
